4-106316858-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001142416.2(AIMP1):c.-26+264A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0413 in 442,586 control chromosomes in the GnomAD database, including 495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.037 ( 156 hom., cov: 32)
Exomes 𝑓: 0.043 ( 339 hom. )
Consequence
AIMP1
NM_001142416.2 intron
NM_001142416.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.948
Genes affected
AIMP1 (HGNC:10648): (aminoacyl tRNA synthetase complex interacting multifunctional protein 1) The protein encoded by this gene is a cytokine that is specifically induced by apoptosis, and it is involved in the control of angiogenesis, inflammation, and wound healing. The release of this cytokine renders the tumor-associated vasculature sensitive to tumor necrosis factor. The precursor protein is identical to the p43 subunit, which is associated with the multi-tRNA synthetase complex, and it modulates aminoacylation activity of tRNA synthetase in normal cells. This protein is also involved in the stimulation of inflammatory responses after proteolytic cleavage in tumor cells. Multiple transcript variants encoding different isoforms have been found for this gene. A pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 4-106316858-A-G is Benign according to our data. Variant chr4-106316858-A-G is described in ClinVar as [Benign]. Clinvar id is 1283130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0543 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIMP1 | NM_001142416.2 | c.-26+264A>G | intron_variant | ENST00000672341.1 | NP_001135888.2 | |||
AIMP1 | NM_001142415.2 | c.-26+1222A>G | intron_variant | NP_001135887.1 | ||||
AIMP1 | NM_004757.4 | c.-26+514A>G | intron_variant | NP_004748.2 | ||||
AIMP1 | XM_047416410.1 | c.-26+48A>G | intron_variant | XP_047272366.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIMP1 | ENST00000672341.1 | c.-26+264A>G | intron_variant | NM_001142416.2 | ENSP00000500620.1 |
Frequencies
GnomAD3 genomes AF: 0.0374 AC: 5690AN: 152174Hom.: 156 Cov.: 32
GnomAD3 genomes
AF:
AC:
5690
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0434 AC: 12592AN: 290294Hom.: 339 AF XY: 0.0426 AC XY: 6381AN XY: 149670
GnomAD4 exome
AF:
AC:
12592
AN:
290294
Hom.:
AF XY:
AC XY:
6381
AN XY:
149670
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0373 AC: 5686AN: 152292Hom.: 156 Cov.: 32 AF XY: 0.0363 AC XY: 2700AN XY: 74458
GnomAD4 genome
AF:
AC:
5686
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
2700
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at